Profs Carl Philpott and Claire Hopkins discuss how the MACRO trial challenges long-held assumptions about chronic ...

Significant unmet needs among people with RA-ILD have been identified in a recent survey, with clear gaps in the services ...

Regional and demographic variations persist in melanoma BRAF testing and patients with these tumours experience poorer five-year survival.

Managing the future risks of type 2 diabetes and cancer in people with prediabetes should be tailored to the age of ...

The 2025 ERS Congress highlighted the emerging challenges and innovations reshaping respiratory medicine, as Ravijyot Saggu ...

Clinical advantage observed in refractory atopic dermatitis with lebrikizumab plus topical corticosteroids where ciclosporin ...

Patients with chronic hand eczema often have limited effective and well-tolerated topical treatment options, a real-world ...

Dr Chiara Re and Prof Grant Stewart discuss the UK’s first one-stop renal mass biopsy clinic for suspected renal cancer and ...

A newly developed 10-minute scan could improve the diagnosis and treatment of suspected primary aldosteronism, a UK pilot ...

Significant variability in the microbiome research methods that inform treatments for gastrointestinal diseases has been exposed.

Mr Vanash Patel, consultant colorectal surgeon at West Hertfordshire Teaching Hospitals NHS Trust, discusses his recent research exploring real-world outcomes, learning curves and operational ...

An international survey highlights how clinicians assess patient suitability for the first-line combination of enfortumab vedotin and pembrolizumab (EV-P) in advanced urothelial malignancies.